@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix drugbank: <https://identifiers.org/drugbank:> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix sub: <https://w3id.org/np/RAVa8rYyK0tqBzEgMgpv62GzjhGe-P_ek99TXT4ajygIs/> .
@prefix this: <https://w3id.org/np/RAVa8rYyK0tqBzEgMgpv62GzjhGe-P_ek99TXT4ajygIs> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <doid:1040> a biolink:Disease .
  
  drugbank:DB09054 a biolink:Drug .
  
  sub:_1 a rdf:Statement;
    rdf:object <doid:1040>;
    rdf:predicate biolink:treats;
    rdf:subject drugbank:DB09054;
    rdfs:label "zydelig is a kinase inhibitor indicated for the treatment of patients with relapsed chronic lymphocytic leukemia";
    biolink:association_type biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    biolink:relation schema:TreatmentIndication .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1825-0097 .
}

sub:pubinfo {
  this: prov:generatedAtTime "2026-09-15T02:55:54.240946+00:00"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-1825-0097 .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEArqKZSXbPuYunZHa+QdtLipGWGs3V19zM1Tjvthi4Cns8JI+WjifCDEHlosw4KbXpd+zQv2uetduOYLDeYOoZMjU4EtnX9wh3/HcpUYp3+jtRmwWjB4whLGI5CAhWHVN/NbXbF9xnYDz22EYyLdXl0qNInHB8lz44Vr96eADh2CT/8Rz+iooFnZMMbTFl5mF2K6Jig+kyFTdn7vQLJHWztnd1id4ofBKfoAkHdW93sQMJik8r6sP4D7EOUf8qg0lbR6wgGAFF2h1pYehljYvqCPhRV5UAZ1C7GAaBUi04Nhb7mhO2kUUIKxypkXFsXBJCYW9QFp1nI0Nb3H+N7O4XDQIDAQAB";
    npx:hasSignature "C3YFDRTZcgJvAguhP/6poD5vWJfnjJ+UAvkuhUhJs5yto4kEE/eLiT5Vbe6uWyaXws6QwRrRFwqPPlN8tReDglsMRlPCgnAwlYr5bvBDL6Lom1FnwdbQnSlcGw4uvo8BN6I3eo3JVzGmZTyW/aeVJP8Y0p6HX1VU04KXm9pRju8z29Ho1S7p27SajZA85Z/yBnKnxT9aaNqec0uC10WuVDbkf0vm0KjJQFLgmu4d1pWi1IwCzQKYGHBuM9R1XSxkQUW5kxLoxxXohC4TXfhLF9WYuMwNsJW+g/MkN62k7NQHyQsZvxVLBzU4BfdWJPWxaAfrAnUIoqhMOAUV9Brdgw==";
    npx:hasSignatureTarget this:;
    npx:signedBy orcid:0000-0002-1825-0097 .
}